Trial Details
COMPLETEDBasic Information
| Clinical ID | c1098 |
|---|---|
| Identifier | NCT01959282 |
| Trial Title | A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | DRUG: Placebo|DRUG: JNJ-54781532 25 mg once daily|DRUG: JNJ-54781532 75 mg once daily|DRUG: JNJ-54781532 150 mg once daily|DRUG: JNJ-54781532 75 mg twice daily |
Participant Information
| Sponsor | Janssen Research & Development, LLC |
|---|---|
| City | La Jolla |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2013-11-15 |
|---|---|
| Primary Completion Date | 2015-05-20 |
| Completion Date | 2015-12-05 |